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The S h o rt-A ctin g B a r b itu r a te s As
In trav en ou s A n esth etics
By A. H. MALONEY, Ph.D., M. D., Washington, D. C.
N 1875, Oré1successfully employed chloral
hydrate intravenously in the production
of general anesthesia. Since that time vari
ous other hypnotics, such as methyl-propyl
carbinol-urethane (Hedonal), trichlorisopropyl alcohol (Isopral), isoamyl-ethyl (Amy
tal), secondary-butyl-bromallyl (Pernoston),
ethyl-1:methyl-butyl (Nembutal), and cyclohexenyl-ethyl (Phanodorn) barbituric acid,
and even ether in Ringer’s solution have
been employed.
The use of the barbiturates dates back
only to 1929. It was in that year that
Zerfas2 and his co-workers, at the Indiana
University School of Medicine and Hos
pitals, found that Sodium Amytal wTas capa
ble of producing surgical anesthesia. How
ever, it was soon found that this and the
other barbiturates named above exhibited
definite disadvantages when employed as
general anesthetics. Patients subjected to
them were prone to sleep unduly long postoperatively, and about 25 percent showed
extreme hyperexcitability, either during in
duction or following the operation. As a
consequence, their use was restricted to the
field of basal anesthesia.
In 1932, methyl-cyclohexenyl-methyl bar
bituric acid (Evipan) was synthesized. Used
as the sodium salt, this barbiturate quickly
gained favor as a general anesthetic, first
in Europe and later in America, for use in
operations of short duration (15 to 20 min
utes). It was characterized by the produc
tion of rapid induction, good somatic and
visceral relaxation, seldom an alarming fall
of blood pressure, satisfactorily short post
operative narcosis, and usually no post
operative gastric disturbances.
Patients
who have been anesthetized with it have
expressed satisfaction.
Following in the wake of Evipal, there
have appeared sodium ethyl-1 :methyl-butylthio-barbiturate (Thio-Nembutal, or Pentothal Sodium), sodium allyl secondary-butylthio-barbiturate (Thiosebutal) ,andl :methyl(5-5) allyl-isopropyl barbiturate (Narconumal). These compounds manifest a strik
ing similarity of dynamic action, excepting
the fact that Pentothal is approximately
one-third more toxic than Evipal; and Thalheimer3, who has used Narconumal more

I

than Evipal, prefers the former, claiming
for it an absence of the factor of excite
ment. Although I have used them all, I
have had widest experience with Evipal and
prefer it to the others solely on that ac
count. My discussion will be confined to
Evipal Soluble, though I would have it un
derstood that whatever is said of Evipal
applies equally as well to the other members
of this particular group.
Discussion
Every anesthetic agent has its peculiar
disadvantages and limitations. In the study
of any therapeutic agent it is imperative to
know its particular limitations and disad
vantages. This is the best safeguard against
bringing a good agent into disrepute.
Among the limitations and disadvantages of
this group of barbiturates, used for intra
venous anesthesia, should be mentioned the
following:
1.— Toxicity and Absorption: From the
results of an extensive experience with lab
oratory animals, and a somewhat more lim
ited clinical experience with Evipal, I have
been able to make some interesting observa
tions regarding the question of the toxicity
of this compound. The problem of toxicity,
within reasonable limits, is a function of the
rate and mode of administration, rather
than the size of the individual dose. This
is due to the fact that absorption plays a
more dominant role than the quantity ad
ministered. Thus, when Evipal is given by
mouth or subcutaneously, the rate of ab
sorption may be so slow that detoxification
within the system may run almost parallel
with absorption. In this event the amount
actually administered over a period of time
could reach startling figures. As the equa
tion shifts from the side of absorption, the
end-point of an otherwise surely fatal dose
might be expressed merely in terms of
stupor, dizziness, or incoordination.
Two years ago, Maloney and Hertz4 re
ported on this point as follows: “ The hazard
of toxicity is inherent, not in the drug per
se, but rather in its absorption constant in
the system in any unit of time.” When
administered intravenously, in which case
absorption is immediate, Evipal presents a
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distinct problem in toxicity. If the rate is too
Evipal is almost wholly detoxified by the
liver. If liver function is definitely im
rapid, it may produce sudden paralysis of
the respiratory center, resulting in death or
paired, a normal therapeutic dose of Evipal
might prove fatal. Two cases in point have
profound respiratory embarrassment.
2. —Anesthetic Inefficiency and Tissue come to my attention: The first had a posi
Damage: Under the caption of toxicity and tive Fouchet test, indicative of hepatic dys
function. In spite of this finding, Evipal
absorption, the dangers at both extremes,
incident to the rate of injection, were was employed, contrary to routine instruc
stressed. But here is another problem as tions. The patient had a very stormy post
operative experience. The second case was
sociated with slowness of injection rate.
a patient with burns over a wide surface
This problem is two-fold: (1) Failure to
produce anesthesia due to the fact that de of his body. Evipal was given illadvisedly.
The result was a fatal toxemia.
toxification may run parallel to absorption.
In this case the drug is likely to be blamed
Duration of Anesthesia
when, in fact, the anesthetist is at fault;
and (2) the detoxifying mechanism may
Opinion is unanimous that Evipal makes
break under the severe strain of the large
an ideal anesthetic for operations of short
dose required and permanent liver damage
duration. While I am in hearty accord, it
result from an irreversible toxic cellular
is but fair to point out the triteness of this
reaction.
statement. It holds true for all anesthetics.
3.
—Non-volatility: Anesthetists and pharMy claim is that, with Evipal, shortness of
macologists are agreed on the point that
duration of anesthesia is not definitive.
an acceptable anesthetic is one that is easily
Within reasonable limits (such as are
controllable. By their very nature the vola allowed for any other anesthetic agent), it
tile anesthetics meet this criterion. Regard makes no difference how short or long a
ing the barbiturates used for general anes time the anesthesia under Evipal is to last.
thesia there are conflicting opinions. Without
Safety of induction is the problem of first
any pretentions at settling the question, I consideration. When once induction has
am prepared to state that picrotoxin, the been successfully obtained, duration becomes
most effective antidote for barbiturate in a matter of fractional injection, as required
toxication, serves as a good control in Evipal
to maintain a given level of anesthesia with
anesthesia, both prophylactically and antismoothness. Provided that the respiratory
dotally. I use picrotoxin prophylactically
center is; given adequate protection by the
as a routine measure to protect the respira prophylactic employment of picrotoxin, any
tory center from the paralyzing action of
ordinary operation may be performed, re
Evipal in an overdose.
gardless of time. I found, in our first series
of 40 cases, that the average duration was
Unsuitable Cases
58.85 minutes; 18 lasted 60 minutes or
more; 3 lasted 125, 125, and 133 minutes,
Evipal is not suitable for every case. As
respectively.
with other anesthetic agents, a judicious
selection is imperative, in which complicat
Technic of Administration
ing factors and contraindications are to be
recognized. On the question of complicating
The patient is prepared in the usual
factors, Heard5 mentions early bronchiecta manner on the night preceding operation.
sis, diabetes, hypertension, endocarditis, and Morphine, with scopolamine or atropine,
advanced carcinoma. Of course, this list, may be given, if necessary, to insure psychic
with the possible exception of hypertension,
or nervous stability and an adequate amount
would constitute “ complicating factors” with
of restful sleep. However, I would strongly
virtually every sort of anesthetic. If care urge that no sedative be given just before
ful pre- and postoperative management of
the anesthetic, because it complicates the
individual cases falling within these cate general picture by potentiating the depres
gories is exercised, there is no reason why
sant action o f Evipal in a way that cannot
Evipal could not with safety be employed. be measured with accuracy, and thereby pre
It is well tolerated in cases exhibiting hyper vents a correct estimation of the effective
tension, provided there is no significant anesthetizing dose.
Avoidance of these
associated impairment of hepatic function.
factors of danger is of greater importance
Two cases in our series (Maloney6), with
than lessening the initial amount of the
hypertension, showed marked diminution of anesthetic agent.
pressure (240 to 200, and 160 to 88 systolic).
Upon a signal of readiness from the sur
The major contraindication to Evipal
geon, 1 to 2 cc. of a 0.3-percent solution of
anesthesia is direct impairment of liver picrotoxin is injected intramuscularly. The
function or any morbid condition which
patient is then asked to count audibly as
would tax heavily the detoxifying capacity
soon as the needle delivering the Evipal so
of the liver. I cannot stress too strongly
lution is in the vein and the injection started.
the importance of hepatic dysfunction.
The injection is made fairly rapidly until

the patient’s voice fades away. Undue
slowness of the injection rate serves to in
crease the induction time and the initial
amount of the anesthetic required. In man,
the injection rate must be more rapid than
in laboratory animals, because of the rela
tively longer course of the systemic circu
lation in man. Using the same caliber
syringe and needle at all times, the tech
nician quickly learns to gauge the optimal
rate of injection.
With the fading off of the patient’s voice,
an additional one-third of the amount
already delivered is then given. The ad
ministration is now stopped, the needle
being held in position in the vein for subse
quent fractional injections. The signal is
now given the surgeon to begin. No special
apparatus is necessary, though there is a
simple device available for use in intra
venous anesthesia. This apparatus is de
scribed by Jarman and Abel7, in The Lancet
for March 4, 1936.
Dosage
The amount of Evipal necessary to pro
duce surgical anesthesia varies with the
individual. In our series the average dose
per patient happened to be 1.875 Gm., the
largest single dose being 4.7 Gm. The prime
consideration here is, not the total amount,
but rather the distribution of that amount.
Our fractional doses are characterized by
smallness and frequency rather than quan
tity, ever bearing in mind the maintenance

of a constant level of anesthesia. In this
connection I take the quality of the respira
tion as my cardinal guide. Under Evipal
anesthesia the respiration closely resembles
deep physiologic sleep, with a gentle stertor
of definite depth and rhythmicity. The
minutest detectable deviation from an estab
lished rhythm and depth is taken as a sign
for either giving or withholding the anes
thetic.
It is imperative to call attention at this
point to the necessity of keeping the airway
clear at all times. An obstruction may
serve to disturb the depth and rhythm of
respiration. It is good procedure to use a
mechanical airway ( Cornell’s), unless it
causes gagging. Should postoperative rest
lessness occur, morphine furnishes prompt
relief (Maloney6).
References
1. — Ore, P .: “ Etudes cliniques sur l’anesthesie chirurgicale par la methode de injections de chloral dans
les veines.” Paris, 1875.
2.
— Zerfas, L. C., and McCallum, J. T. C .: The Clin
ical Use of Sodium Iso-amyl-ethyl Barbiturate.
Anesth. and Analges., November-December, 1929.
3. — Thalheimer, M .: Anesthesia par injections intraveineuses d’acide 1-methyl 5, 5-allyl-isopropyl barbiturique. Anesth. and Analges., November, 1936.
4. — Maloney, A. H., and Hertz, R .: Experiments
with Evipal in Prolonged Anesthesia. J. Lab. and
Clin. Med., Sept., 1935.
5. — Heard, K .: Clinical Observations on Use of
Evipan. Can. Med. Assoc. J., December, 1934.
6. — Maloney, A . H .: The Protective Action of Picrotoxin in Prolonged Surgical Anesthesia with Evipal.
A. J. Surg., December, 1936.
7. — Jarman, R., and Abel, L .: Technic of Intra
venous Anesthesia. Lancet, March 14, 1936.

